
Dr. Kat Toups discusses research breakthroughs in preventing Alzheimer's and cognitive decline through a personalized, precision-medicine approach.
Guest: Dr. Kat Toups What if memory loss and cognitive decline aren’t the inevitable parts of aging we’ve been led to believe? In this episode, our guest is psychiatrist and clinical researcher Dr. Kat Toups, a Distinguished Fellow of the American Psychiatric Association, who shares hopeful, research-based insights that are reshaping how we understand brain aging and Alzheimer’s disease. For decades, most Alzheimer’s clinical trials have focused on single solutions—usually drugs—targeting one aspect of the disease. Despite massive investment, these approaches have delivered limited results. Dr. Toups explains why this one-size-fits-all model often falls short: Cognitive decline rarely has a single cause. Drawing from recent proof-of-concept and randomized controlled trials, Dr. Toups shares with host Deborah Rozman compelling evidence that a personalized, precision-medicine approach—addressing multiple contributors at once—leads to meaningful improvements in memory, thinking speed, and overall brain function, even in people with mild cognitive impairment and early-stage dementia. In her soon-to-be-published paper, titled Precision Medicine Treatment of Alzheimer’s Disease…
Explore listener stats, chart rankings, contacts and more on the HeartMath's Add Heart podcast page.